Corrigendum: Rehabilitation training and resveratrol improve the recovery of neurological and motor function in rats after cerebral ischemic injury through the sirt1 signaling pathway (BioMed Research International (2016) 2016 (1732163) DOI: 10.1155/2016/1732163);Rehabilitation Training and Resveratrol Improve the Recovery of Neurological and Motor Function in Rats after Cerebral Ischemic Injury through the Sirt1 Signaling Pathway

BioMed Research International

Volumn 2016, Issue , 2016, Pages

  Shi, Na ^a   Zhu, Chongtian ^a   Li, Liying ^b  

^a LINYI PEOPLE'S HOSPITAL   (China)

^b Shandong Medical College   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; RESVERATROL; SIRTUIN 1; NONSTEROID ANTIINFLAMMATORY AGENT; SIRT1 PROTEIN, RAT; STILBENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR ASSESSMENT; BRAIN FUNCTION; BRAIN ISCHEMIA; BRAIN TISSUE; COMPARATIVE STUDY; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR PERFORMANCE; NONHUMAN; RAT; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRAINING; TREATMENT DURATION; WESTERN BLOTTING; ANIMAL; COMPLICATION; CONVALESCENCE; DRUG EFFECTS; KINESIOTHERAPY; METABOLISM; MOVEMENT DISORDERS; MULTIMODALITY CANCER THERAPY; NEUROREHABILITATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRAIN ISCHEMIA; COMBINED MODALITY THERAPY; EXERCISE THERAPY; MALE; MOVEMENT DISORDERS; NEUROLOGICAL REHABILITATION; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SIRTUIN 1; STILBENES; TREATMENT OUTCOME;

EID: 85009454931     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2017/1532462     Document Type: Erratum

References (31)

1. G. Liu, "Research progress of ischemic cerebrovascular diseases," Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease, vol. 21, pp. 5-6, 2013.
2. Y. Suzuki, N. Nagai, and K. Umemura, "A review of themechanisms of blood-brain barrier permeability by tissue-type plasminogen activator treatment for cerebral ischemia," Frontiers in Cellular Neuroscience, vol. 10, article 2, 2016.
3. E. Behravan, B. M. Razavi, and H. Hosseinzadeh, "Review of plants and their constituents in the therapy of cerebral ischemia," Phytotherapy Research, vol. 28, no. 9, pp. 1265-1274, 2014.
4. Y. Zhang, C. Li, and L. Niu, "Effects of rehabilitation training on motor function recovery and cAMP-PKA signal transduction pathway after ischemic stroke in rats," Acta Laboratorium Animalis Scientia Sinica, vol. 21, pp. 46-49, 2013.
5. L. Niu, Y. Zhang, C. Li, B. Liu, Y. LJiang, and L. Li, "cAMP /PKA-pCREB signal transduction pathway may mediate a promoting effect of rehabilitation training on motor function after ischemic stroke in rats," Acta Laboratorium Animalis Scientia Sinica, vol. 22, pp. 24-29, 2014.
6. T. Gan, L. Li, and S. Chen, "Effect of rehabilitation training on the recovery of motor function and expression of Nogo-A and Ng R in rats with focal cerebral ischemia reperfusion injury," Chinese Journal of RehabilitationMedicine, vol. 28, pp. 768-770, 2013.
7. T. L. Briones, J. Woods, M. Wadowska, M. Rogozinska, and M. Nguyen, "Astrocytic changes in the hippocampus and functional recovery after cerebral ischemia are facilitated by rehabilitation training," Behavioural Brain Research, vol. 171, no. 1, pp. 17-25, 2006.
8. J.-S. Seo, M.-H.Moon, J.-K. Jeong et al., "SIRT1, a histone deacetylase, regulates prion protein-induced neuronal cell death," Neurobiology of Aging, vol. 33, no. 6, pp. 1110-1120, 2012.
9. G. Zu, A. Ji, T. Zhou, and N. Che, "Clinicopathological significance of SIRT1 expression in colorectal cancer: a systematic review and meta analysis," International Journal of Surgery, vol. 26, pp. 32-37, 2016.
10. Y. Wang, Y. Liang, and P. M. Vanhoutte, "SIRT1 and AMPK in regulating mammalian senescence: a critical reviewand aworking model," FEBS Letters, vol. 585, no. 7, pp. 986-994, 2011.
11. F. Xue, J.W. Huang, P. Y. Ding et al., "Nrf2/antioxidant defense pathway is involved in the neuroprotective effects of Sirt1 against focal cerebral ischemia in rats after hyperbaric oxygen preconditioning," Behavioural Brain Research, vol. 309, pp. 1-8, 2016.
12. K. B. Koronowski and M. A. Perez-Pinzon, "Sirt1 in cerebral ischemia," Brain Circulation, vol. 1, no. 1, pp. 69-78, 2015.
13. Z. Meng, J. Li, H. Zhao et al., "Resveratrol relieves ischemiainduced oxidative stress in the hippocampus by activating SIRT1," Experimental and Therapeutic Medicine, vol. 10, no. 2, pp. 525-530, 2015.
14. Y. Hattori, Y. Okamoto, K. Nagatsuka et al., "SIRT1 attenuates severe ischemic damage by preserving cerebral blood flow," NeuroReport, vol. 26, no. 3, pp. 113-117, 2015.
15. Y. Yang,W. Duan, Y. Li et al., "New role of silent information regulator 1 in cerebral ischemia," Neurobiology of Aging, vol. 34, no. 12, pp. 2879-2888, 2013.
16. Z. Ungvari, Z. Bagi, A. Feher et al., "Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2,"American Journal of Physiology-Heart and Circulatory Physiology, vol. 299, no. 1, pp. H18-H24, 2010.
17. L.-G. Huang, J.-P. Li, X.-M. Pang et al., "MicroRNA-29c correlates with neuroprotection induced by FNS by targeting both Birc2 and Bak1 in rat brain after stroke," CNS Neuroscience and Therapeutics, vol. 21, no. 6, pp. 496-503, 2015.
18. K. J. Livak and T. D. Schmittgen, "Analysis of relative gene expression data using real-time quantitative PCR and the 2 method," Methods, vol. 25, no. 4, pp. 402-408, 2001.
19. J.-P. Wang, C. Liu, Z.-T. Yang, C. Jiang, Y.-Z. Zhao, and D.-Q. Xu, "Effects of resveratrol on brain derived neurotrophic factor and neurotrophin-3 of cerebral ischemia of mice," Chinese Pharmacological Bulletin, vol. 28, no. 4, pp. 531-535, 2012.
20. J. Zhao, H. Xu, Y. Tian, M. Hu, and H. Xiao, "Effect of electroacupuncture on brain-derived neurotrophic factor mRNA expression in mouse hippocampus following cerebral ischemiareperfusion injury," Journal of Traditional ChineseMedicine, vol. 33, no. 2, pp. 253-257, 2013.
21. X. L. Shu, Y. S. Zhang, H. Xu, K. Kang, and D. L. Cai, "Brainderived neurotrophic factor inhibits glucose intolerance after cerebral ischemia," Neural Regeneration Research, vol. 8, no. 25, pp. 2370-2378, 2013.
22. C.D. Pandya, A. Kutiyanawalla, andA. Pillai, "BDNF-TrkB signaling and neuroprotection in schizophrenia," Asian Journal of Psychiatry, vol. 6, no. 1, pp. 22-28, 2013.
23. R. Andero, D. C. Choi, and K. J. Ressler, "BDNF-TrkB receptor regulation of distributed adult neural plasticity,memory formation, and psychiatric disorders," Progress in Molecular Biology and Translational Science, vol. 122, pp. 169-192, 2014.
24. R.-Q. Yao, D.-S. Qi, H.-L. Yu, J. Liu, L.-H. Yang, and X.-X.Wu, "Quercetin attenuates cell apoptosis in focal cerebral ischemia rat brain via activation of BDNF-TrkB-PI3K/Akt signaling pathway," Neurochemical Research, vol. 37, no. 12, pp. 2777-2786, 2012.
25. B. Qiu, S. Hu, L. Liu et al., "CART attenuates endoplasmic reticulum stress response induced by cerebral ischemia and reperfusion through upregulating BDNF synthesis and secretion," Biochemical and Biophysical Research Communications, vol. 436, no. 4, pp. 655-659, 2013.
26. J.-Y. Chung, M.-W. Kim, M.-S. Bang, and M. Kim, "Increased expression of neurotrophin 4 following focal cerebral ischemia in adult rat brain with treadmill exercise," PLoS ONE, vol. 8, no. 3, Article ID e52461, 2013.
27. R. Bai, X. Liang, and K.Wang, "Effects of rehabilitation training on the neurological behavior and the expression of BDNF, CaBP-D28k for focal cerebral ischemia of rats," Shangdong Medicine Journal, vol. 52, 2012.
28. F. Angelucci, J. Piermaria, F. Gelfo et al., "The effects of motor rehabilitation training on clinical symptoms and serum BDNF levels in Parkinson's disease subjects," Canadian Journal of Physiology and Pharmacology, vol. 94, no. 4, pp. 455-461, 2016.
29. Y. Zeng and K. Yang, "Sirtuin 1 participates in the process of age-related retinal degeneration," Biochemical and Biophysical Research Communications, vol. 468, no. 1-2, pp. 167-172, 2015.
30. M. Jiang, J. Wang, J. Fu et al., "Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation ofmultiple Sirt1 targets," Nature Medicine, vol. 18, no. 1, pp. 153-158, 2012.
31. G.Wang, B. Liu, J. Lv,Y.Zhao, andR.Zhao, "The expressions of brain-derived neurotrophic factor and tyrosine kinase B in the rats model of ischemic postconditioning," Journal of Brain and Nervous Diseases, vol. 24, pp. 34-39, 2016.